Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease
International Journal of Molecular Sciences · 07.02.2025 · 26 (4) · 1403
DOI: 10.3390/ijms26041403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.02.2025. Verfasst von Marija M Stankovic. Beteiligte Einrichtung: Group for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Lung, Microbiota. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science, Technological Development and Innovations Republic of Serbia.
Themen: COPD
Abstract (Originalsprache)
Lung health is dependent on a complex picture of the lung microbiota composed of bacteriobiota, mycobiota, and virome. The studies have demonstrated that the lung microbiota has a crucial role in host protection by regulating innate and adaptive lung immunity. Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease featuring changed microbiota composition and diversity, known as a dysbiosis. The lung dysbiosis increases with the progress of COPD and during exacerbation. Two models of dysbiosis have been proposed: dysbiosis and inflammation cycles and the disturbance of bacterial interactome. Still, it is unknown if the driving factor of the pathogenesis of COPD belongs to the host or microbiota. Recently, host–microbiota and microbe–microbe interactions have been highlighted in COPD, but the mechanisms behind these interactions need further exploration. The function of the gut–lung axis is crucial for the maintenance of lung health and is affected in COPD. The application of probiotics has resulted in host–beneficial effects, and it is likely that future progress in this field will aid in the therapy of COPD. In this review, the composition of the lung microbiota, molecular mechanisms, and clinical aspects relating to host and microbiota in health and COPD are comprehensively provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Group for Molecular Biology, Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, 11042 Belgrade, Serbia.
ORCID-Profile: Marija M Stankovic
Förderung
- Ministry of Science, Technological Development and Innovations Republic of Serbia
Zitieren
APA
Stankovic, M. M. (2025). Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences, 26(4), 1403. https://doi.org/10.3390/ijms26041403
Vancouver
Stankovic MM. Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences. 2025;26(4):1403. doi:10.3390/ijms26041403
BibTeX
@article{Stankovic2025,
author = {Stankovic, Marija M},
title = {Lung Microbiota: From Healthy Lungs to Development of Chronic Obstructive Pulmonary Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1403},
doi = {10.3390/ijms26041403}
}
EUVIMED